Search

Lessons learned from running a national thyroid surgery registry

The UK Registry of Endocrine and Thyroid Surgery is now yielding the rewards of meticulous data collection and years of hard work. David Scott-Coombes discusses the advantages and the unintended consequences of their success. The British Association of Endocrine and...

Musical perception and the brain: In conversation with Charles Limb

One of the unique aspects of BACO 2020 will be a public engagement event. Charles Limb, an esteemed guest lecturer from San Francisco, will delve deep into the neurological experience of music. Who better than our very own Declan Costello...

Head and neck cancer multidisciplinary team

Why do we have MDTs? Do they make a difference to outcomes? Jon Bernstein explores the whys and wherefores of the head and neck cancer MDT, and wonders where things might go from here… Head and neck (upper aerodigestive tract)...

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Help shape the future of mild to moderate hearing loss research

A James Lind Alliance Priority Setting Partnership has been formed to help shape the future of research into mild-moderate hearing loss. Who is the Priority Setting Partnership? The Partnership brings together Hearing Link, Action on Hearing Loss, the British Society...

The impact of hearing loss in children with Down syndrome

Hearing loss and language development Down syndrome (DS) usually arises due to trisomy 21 and is associated with intellectual disability and risks of developmental delays and difficulties, including hearing loss. Hearing loss is common in children with DS [1]. In...

Genetics WG4. Improving diagnosis and drug development through the genetic understanding of tinnitus subtypes: a TINNET endeavour

Christopher R Cederroth and Jose Antonio Lopez-Escamez explain how progress is being made to investigate the contribution of genetic factors to tinnitus, including a subtype of ‘extreme’ tinnitus in Ménière’s disease. Genetics WG4 is working towards determining the genetic basis...

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.